Dr. Frank van Leth
Frank van Leth
Clinical Reasoning Underlying Guideline Nonadherence in Urinary Tract Infections in Nursing Homes
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
Unbiased antimicrobial resistance prevalence estimates through population-based surveillance
Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model
Diapers as Promising Alternative Collection Method for Urine Specimens in Nursing Home Residents: A Noninferiority Study.
Defining Outcomes of Tuberculosis (Treatment): From the Past to the Future.
Antimicrobial resistance among uropathogens in the Asia-Pacific region: a systematic review
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model.
Appropriateness of diagnosis and antibiotic use in sepsis patients admitted to a tertiary hospital in Indonesia.
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.
Laboratory-based versus population-based surveillance of antimicrobial resistance to inform empirical treatment for suspected urinary tract infection in Indonesia
Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials.
The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR.
Sensitivity of point-of-care testing C reactive protein and procalcitonin to diagnose urinary tract infections in Dutch nursing homes: PROGRESS study protocol
Changes in disclosure, adherence and healthcare interactions after the introduction of immediate ART initiation: an analysis of patient experiences in Swaziland
Bridging the TB data gap: in silico extraction of rifampicin-resistant tuberculosis diagnostic test results from whole genome sequence data.
Rethinking Antimicrobial Resistance Surveillance: A Role for Lot Quality Assurance Sampling.
The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation.
Pharmacy-based hypertension care employing mHealth in Lagos, Nigeria - a mixed methods feasibility study.
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries
Predictive value of the urinary dipstick test in the management of patients with urinary tract infection-associated symptoms in primary care in Indonesia: a cross-sectional study.
Testing for LTBI: more of the same or a step forward?
Relapse-free cure from multidrug-resistant tuberculosis in Germany
Time to revise WHO-recommended definitions of MDR-TB treatment outcomes
Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria
Treatment outcomes of MDR-TB and HIV co-infection in Europe
An easy tool to assess ventilation in health facilities as part of air-borne transmission prevention: a cross-sectional survey from Uganda
Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia
Rapid assessment of antimicrobial resistance prevalence using a Lot Quality Assurance sampling approach
Effect of secondary preventive therapy on recurrence of tuberculosis in HIV-infected individuals: a systematic review
Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure
Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial
Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe
Intention of physicians to implement guidelines for screening and treatment of latent tuberculosis infection in HIV-infected patients in The Netherlands: a mixed-method design
Treatment Outcomes in Multidrug-Resistant Tuberculosis
TB-HIV co-infection in the Netherlands: estimating prevalence and under-reporting in national registration databases using a capture-recapture analysis
Viral Load and Risk of Tuberculosis in HIV Infection
More on Treatment Outcomes in Multidrug-Resistant Tuberculosis
Numbers needed to treat to prevent tuberculosis
Factors associated with poor knowledge among adults on tuberculosis in Bangladesh: results from a nationwide survey
Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey
Multidrug-resistant tuberculosis in europe, 2010-2011
Latent tuberculosis infection as a target for tuberculosis control
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study
Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review
Care seeking in tuberculosis: results from a countrywide cluster randomised survey in Bangladesh
Embracing the challenges of HIV-TB co-infection in children
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
Antiretroviral therapy and tuberculosis: does the regimen matter?
Design of pragmatic trials of tuberculosis interventions
Healthcare workers' challenges in the implementation of tuberculosis infection prevention and control measures in Mozambique
TB diagnostic process management of patients in a referral hospital in Mozambique in comparison with the 2007 WHO recommendations for the diagnosis of smear-negative pulmonary TB and extrapulmonary TB
Are routine tuberculosis programme data suitable to report on antiretroviral therapy use of HIV-infected tuberculosis patients?
Comparison of direct versus concentrated smear microscopy in detection of pulmonary tuberculosis
Epidemiology of tuberculosis in an urban slum of Dhaka City, Bangladesh
Health workers' performance in the implementation of Patient Centred Tuberculosis Treatment (PCT) strategy under programmatic conditions in Tanzania: a cross sectional study
Predictive value of the tuberculin skin test among newly arriving immigrants
Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting
Role of the QuantiFERON(R)-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection
Unrecognised tuberculosis at antiretroviral therapy initiation is associated with lower CD4+ T cell recovery
Implementation and effect of intensified case finding on diagnosis of tuberculosis in a large urban HIV clinic in Uganda: a retrospective cohort study
Missed opportunities in tuberculosis control in The Netherlands due to prioritization of contact investigations
Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance sampling
Adherence by Dutch public health nurses to the national guidelines for tuberculosis contact investigation
Adherence to tuberculosis therapy among patients receiving home-based directly observed treatment: evidence from the United Republic of Tanzania
Socio economic position in TB prevalence and access to services: results from a population prevalence survey and a facility-based survey in Bangladesh
The effect of tuberculosis and antiretroviral treatment on CD4+ cell count response in HIV-positive tuberculosis patients in Mozambique
Contact tracing in low-incidence tuberculosis settings
Incidence and Predictors of Mortality and the Effect of Tuberculosis Immune Reconstitution Inflammatory Syndrome in a Cohort of TB/HIV Patients Commencing Antiretroviral Therapy
Guidelines for conducting tuberculin skin test surveys in high-prevalence countries